Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Work In Process (2018 - 2021)

Medifast (MED) has disclosed Work In Process for 4 consecutive years, with $3.4 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Work In Process rose 22.96% year-over-year to $3.4 million, compared with a TTM value of $3.4 million through Sep 2021, up 22.96%, and an annual FY2020 reading of $4.1 million, down 0.92% over the prior year.
  • Work In Process was $3.4 million for Q3 2021 at Medifast, up from $3.0 million in the prior quarter.
  • Across five years, Work In Process topped out at $4.1 million in Q4 2019 and bottomed at $1.6 million in Q4 2018.
  • Average Work In Process over 4 years is $2.9 million, with a median of $2.9 million recorded in 2020.
  • The sharpest move saw Work In Process surged 162.89% in 2019, then dropped 23.13% in 2020.
  • Year by year, Work In Process stood at $1.6 million in 2018, then soared by 162.89% to $4.1 million in 2019, then fell by 0.92% to $4.1 million in 2020, then dropped by 16.61% to $3.4 million in 2021.
  • Business Quant data shows Work In Process for MED at $3.4 million in Q3 2021, $3.0 million in Q2 2021, and $2.5 million in Q1 2021.